AFFILIATIONS
1 Tel Aviv Medical Center, Tel Aviv, Israel, Tel Aviv University, Tel Aviv, Israel
2 University Hospital Hamburg-Eppendorf, Hamburg, Germany
3 Australia and New Zealand Transplant and Cellular Therapies Ltd (ANZTCT), Sydney, NSW, Australia
4 Australia and New Zealand Transplant and Cellular Therapies Ltd (ANZTCT), Sydney, NSW, Australia
5 DKMS Clinical Trials Unit, Dresden, Germany, Technical University Dresden, University Hospital, Dresden, Germany
6 University Hospital Basel, Switzerland, Basel, Switzerland
7 KU Leuven, Leuven, Belgium., Leuven, Belgium
8 University Hospital Regensburg, Regensburg, Germany
9 Tel Aviv Medical Center, Tel Aviv, Israel, Tel Aviv University, Tel Aviv, Israel
10 University Hospital Regensburg, Regensburg, Germany
11 University Hospital Regensburg, Regensburg, Germany
12 Bavarian Center for Cancer Research (BZKF), Germany, Regensburg, Germany, University Hospital Regensburg, Regensburg, Germany, University of Regensburg, Regensburg, Germany
ABSTRACT
Introduction Allogeneic hematopoietic cell transplantation (alloHCT) requires effective communication between patients and physicians. Evidence suggests it frequently fails on multiple layers, as demonstrated by a recent international interview study involving patients after alloHCT complemented by a community advisory board with patients affected with chronic graft-versus-host disease (cGVHD). To gain insights into communication barriers, we interviewed experienced transplant physicians involved in alloHCT follow-up care.
Methods Interviews were conducted in English using a semi-structured guide covering potential communication barriers. Patient-reported communication gaps were discussed to jointly reflect on perceived communication failures. Data collection is ongoing in Israel, Italy, Switzerland, Australia, and Germany.
Results 11 experienced transplant physicians (6 females, 5 males) were interviewed and evaluated by framework analysis, with a median of 14 years of experience caring for alloHCT recipients [range 2-29]. Communication barriers persist among this experienced group due to:
(1) Clinical prioritization and avoidance of sensitive discussions: Clinicians frequently prioritized acute medical issues (e.g., cGVHD, organ function) and expressed greater comfort discussing objective metrics. Many feared opening a time-consuming “Pandora’s Box,” avoiding psychosocial discussions. Furthermore, physicians explicitly dismissed some quality-of-life topics (e.g., sexual health) as secondary to life-threatening concerns. Interestingly, when taboo topics like sexual health are discussed, they sometimes serve an alternative purpose; female patients may rely on the physician's medical authority to mediate spousal expectations and alleviate partner pressure regarding intimacy.
(2) Communication skills and knowledge gaps: Physicians lacked knowledge and struggled to ask appropriate questions regarding cognitive decline, sexual dysfunction, financial distress, and medication management burden. Additionally, doctors avoided discussing specific lifestyle restrictions, citing a lack of definitive, evidence-based answers in the medical literature.
(3) Systemic and resource limitations: Avoidance was heavily driven by a demanding clinical environment characterized by high patient volumes, emergencies, and limited consultation time. Physicians felt overwhelmed by insufficient access to multidisciplinary support and limited referral pathways. While some centers utilize dedicated post-transplant coordinator nurses to filter clinical noise, the vision of a multidisciplinary "one-stop-shop" remains largely unfulfilled. Clinicians highlighted a mismatch in resources: emotional support is available pre-transplant but conspicuously absent during the outpatient phase. This leads to a disconnect in perceiving distress. While some physicians mistakenly assume patients feel relieved post-discharge, patients actually experience a severe "emotional crash" and profound loneliness upon realizing discharge marks the beginning of a prolonged recovery—a realization contributing to severe, unaddressed caregiver burnout.
(4) Interpersonal and sociocultural barriers: Uncertainty regarding interactions with family members posed a challenge. While helpful, family presence could limit direct patient disclosure regarding intimacy. These challenges were further compounded by culture, religion, language, and gender barriers.
Conclusion Strategies to address these gaps include better patient and caregiver information, symptom self-management support, and active discussion of ignored topics like neurocognitive decline or sexual health. Solutions involve communication training, PROMs, and patient question prompt lists (QPLs). However, implementation must address clinician skepticism; some actively resist QPLs, fearing an unmanageable workload, preferring directive booklets. Conversely, other clinicians strongly advocate for QPLs, emphasizing that written prompts grant patients crucial "legitimacy" to raise taboo topics (e.g., vaginal cGVHD) outside routine exams. Integrating QPLs into digital health applications was suggested as a practical strategy. These tools may also provide supplementary points of contact (e.g., nurses, social workers) to help physicians manage communicative challenges they lack the time or training to address effectively.
DISCLOSURES
Anne Herrmann, PhD, BA, MA: No relevant conflicts of interest to declare.